Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
Resource Type
Article
Authors
Pitisuttithum, Punnee ; Luvira, Viravarn ; Lawpoolsri, Saranath ; Muangnoicharoen, Sant ; Kamolratanakul, Supitcha ; Sivakorn, Chaisith ; Narakorn, Piengthong ; Surichan, Somchaiya ; Prangpratanporn, Sumalee ; Puksuriwong, Suttida ; Lamola, Steven ; Mercer, Laina D. ; Raghunandan, Rama ; Sun, Weina ; Liu, Yonghong ; Carreño, Juan Manuel ; Scharf, Rami ; Phumratanaprapin, Weerapong ; Amanat, Fatima ; Gagnon, Luc ; Hsieh, Ching-Lin ; Kaweepornpoj, Ruangchai ; Khan, Sarwat ; Lal, Manjari ; McCroskery, Stephen ; McLellan, Jason ; Mena, Ignacio ; Meseck, Marcia ; Phonrat, Benjaluck ; Sabmee, Yupa ; Singchareon, Ratsamikorn ; Slamanig, Stefan ; Suthepakul, Nava ; Tcheou, Johnstone ; Thantamnu, Narumon ; Theerasurakarn, Sompone ; Tran, Steven ; Vilasmongkolchai, Thanakrit ; White, Jessica A ; Bhardwaj, Nina ; Garcia-Sastre, Adolfo ; Palese, Peter ; Krammer, Florian ; Poopipatpol, Kittisak ; Wirachwong, Ponthip ; Hjorth, Richard ; Innis, Bruce L
Source
In eClinicalMedicine March 2022 45
Subject
Language
ISSN
2589-5370